PP
PACB icon

Paloma Partners’s Pacific Biosciences PACB Stock Holding History

Paloma Partners’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-36,901
Closed -$62.7K – 863
2024
Q3 		$62.7K Buy
+36,901
New +$60.6K ﹤0.01% 1064
2022
Q2 		– Sell
-15,186
Closed -$138K – 1580
2022
Q1 		$138K Buy
+15,186
New +$175K ﹤0.01% 1518
2021
Q4 		– Sell
-10,177
Closed -$260K – 2049
2021
Q3 		$260K Buy
+10,177
New +$302K 0.01% 769
2021
Q2 		– Sell
-15,394
Closed -$513K – 2142
2021
Q1 		$513K Buy
+15,394
New +$539K 0.01% 1099
2020
Q2 		– Sell
-43,077
Closed -$132K – 2189
2020
Q1 		$132K Buy
+43,077
New +$176K 0.01% 996
2019
Q4 		– Sell
-13,644
Closed -$70K – 2405
2019
Q3 		$70K Sell
13,644
-119,285
-90% -$667K ﹤0.01% 1862
2019
Q2 		$804K Sell
132,929
-91,371
-41% -$641K 0.01% 799
2019
Q1 		$1.62M Buy
224,300
+69,200
+45% +$500K 0.04% 525
2018
Q4 		$1.15M Buy
+155,100
New +$983K 0.04% 411
2017
Q1 		– Sell
-26,600
Closed -$101K – 2166
2016
Q4 		$101K Buy
+26,600
New +$193K ﹤0.01% 1906
2015
Q1 		– Sell
-22,900
Closed -$180K – 1373
2014
Q4 		$180K Buy
22,900
+8,200
+56% +$52.5K 0.01% 1026
2014
Q3 		$72K Buy
+14,700
New +$76.9K ﹤0.01% 923

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.39B AUM 10.34% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Paloma Partners's PACB Position: Q4 2024 in Review

Paloma Partners sold out of Pacific Biosciences (PACB) in Q4 2024, closing a stake of 36,901 shares — an estimated $62.7K sold.

Paloma Partners first reported a position in PACB in Q3 2014 and held it in 12 quarters. The position peaked at $1.62M in Q1 2019. 226 funds tracked by Wall St. Rank hold PACB as of Q4 2024.

  • Paloma Partners reported no remaining Pacific Biosciences position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 36,901 Pacific Biosciences shares in Q4 2024, an estimated $62.7K.
  • Paloma Partners first reported a position in Pacific Biosciences in Q3 2014 and held it in 12 quarters.
  • Paloma Partners's Pacific Biosciences position peaked at $1.62M in Q1 2019.
  • 226 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.